Development of tumor targeting magnetic nanoparticles for cancer therapy

Robert Ivkov, Sally J. DeNardo, Laird A. Miers, Arutselvan Natarajan, Allan R. Foreman, Cordula Gruettner, Grete N. Adamson, Gerald L Denardo

Research output: Chapter in Book/Report/Conference proceedingConference contribution

6 Citations (Scopus)

Abstract

Magnetic nanoparticles will heat when activated by an alternating magnetic field (AMF). Systemic delivery of magnetic nanoparticles conjugated to a monoclonal antibody (MAb) offers potential for selective and minimally invasive cancer treatment by heating the microenvironments of cells containing such particles. 111In-Chimeric L6 (Ch L6) antibody was conjugated to carboxylated polyethylene glycol (PEG-COOH) on dextran-coated iron oxide 20-nm particles to yield bioprobes. Pharmaco-kinetics, histopathology, and AMF/bioprobe therapy were done using intravenous doses (20μg/2.2mg ChL6/ bioprobe) with 50μg ChL6 in athymic mice bearing human breast tumor, HBT3477, xenografts. A 153 kHz AMF was applied 72 hr post injection for therapy using several AMF amplitudes. Significant therapeutic response was demonstrated. Toxicity was observed only at extreme AMF conditions, and was due to nonspecific heating resulting from the AMF.

Original languageEnglish (US)
Title of host publication2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
Pages21-24
Number of pages4
Volume2
StatePublished - 2006
Event2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings - Boston, MA, United States
Duration: May 7 2006May 11 2006

Other

Other2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings
CountryUnited States
CityBoston, MA
Period5/7/065/11/06

Fingerprint

Tumors
Magnetic fields
Nanoparticles
Polyethylene glycols
Bearings (structural)
Heating
Monoclonal antibodies
Pharmacokinetics
Oncology
Dextran
Iron oxides
Antibodies
Toxicity

Keywords

  • Cancer
  • Magnetic nanoparticles
  • Monoclonal antibodies (MAb)
  • Thermoablation

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Ivkov, R., DeNardo, S. J., Miers, L. A., Natarajan, A., Foreman, A. R., Gruettner, C., ... Denardo, G. L. (2006). Development of tumor targeting magnetic nanoparticles for cancer therapy. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings (Vol. 2, pp. 21-24)

Development of tumor targeting magnetic nanoparticles for cancer therapy. / Ivkov, Robert; DeNardo, Sally J.; Miers, Laird A.; Natarajan, Arutselvan; Foreman, Allan R.; Gruettner, Cordula; Adamson, Grete N.; Denardo, Gerald L.

2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 2 2006. p. 21-24.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ivkov, R, DeNardo, SJ, Miers, LA, Natarajan, A, Foreman, AR, Gruettner, C, Adamson, GN & Denardo, GL 2006, Development of tumor targeting magnetic nanoparticles for cancer therapy. in 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. vol. 2, pp. 21-24, 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings, Boston, MA, United States, 5/7/06.
Ivkov R, DeNardo SJ, Miers LA, Natarajan A, Foreman AR, Gruettner C et al. Development of tumor targeting magnetic nanoparticles for cancer therapy. In 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 2. 2006. p. 21-24
Ivkov, Robert ; DeNardo, Sally J. ; Miers, Laird A. ; Natarajan, Arutselvan ; Foreman, Allan R. ; Gruettner, Cordula ; Adamson, Grete N. ; Denardo, Gerald L. / Development of tumor targeting magnetic nanoparticles for cancer therapy. 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings. Vol. 2 2006. pp. 21-24
@inproceedings{4a141e78bd11418e8f3e1308849ca27d,
title = "Development of tumor targeting magnetic nanoparticles for cancer therapy",
abstract = "Magnetic nanoparticles will heat when activated by an alternating magnetic field (AMF). Systemic delivery of magnetic nanoparticles conjugated to a monoclonal antibody (MAb) offers potential for selective and minimally invasive cancer treatment by heating the microenvironments of cells containing such particles. 111In-Chimeric L6 (Ch L6) antibody was conjugated to carboxylated polyethylene glycol (PEG-COOH) on dextran-coated iron oxide 20-nm particles to yield bioprobes. Pharmaco-kinetics, histopathology, and AMF/bioprobe therapy were done using intravenous doses (20μg/2.2mg ChL6/ bioprobe) with 50μg ChL6 in athymic mice bearing human breast tumor, HBT3477, xenografts. A 153 kHz AMF was applied 72 hr post injection for therapy using several AMF amplitudes. Significant therapeutic response was demonstrated. Toxicity was observed only at extreme AMF conditions, and was due to nonspecific heating resulting from the AMF.",
keywords = "Cancer, Magnetic nanoparticles, Monoclonal antibodies (MAb), Thermoablation",
author = "Robert Ivkov and DeNardo, {Sally J.} and Miers, {Laird A.} and Arutselvan Natarajan and Foreman, {Allan R.} and Cordula Gruettner and Adamson, {Grete N.} and Denardo, {Gerald L}",
year = "2006",
language = "English (US)",
isbn = "0976798573",
volume = "2",
pages = "21--24",
booktitle = "2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings",

}

TY - GEN

T1 - Development of tumor targeting magnetic nanoparticles for cancer therapy

AU - Ivkov, Robert

AU - DeNardo, Sally J.

AU - Miers, Laird A.

AU - Natarajan, Arutselvan

AU - Foreman, Allan R.

AU - Gruettner, Cordula

AU - Adamson, Grete N.

AU - Denardo, Gerald L

PY - 2006

Y1 - 2006

N2 - Magnetic nanoparticles will heat when activated by an alternating magnetic field (AMF). Systemic delivery of magnetic nanoparticles conjugated to a monoclonal antibody (MAb) offers potential for selective and minimally invasive cancer treatment by heating the microenvironments of cells containing such particles. 111In-Chimeric L6 (Ch L6) antibody was conjugated to carboxylated polyethylene glycol (PEG-COOH) on dextran-coated iron oxide 20-nm particles to yield bioprobes. Pharmaco-kinetics, histopathology, and AMF/bioprobe therapy were done using intravenous doses (20μg/2.2mg ChL6/ bioprobe) with 50μg ChL6 in athymic mice bearing human breast tumor, HBT3477, xenografts. A 153 kHz AMF was applied 72 hr post injection for therapy using several AMF amplitudes. Significant therapeutic response was demonstrated. Toxicity was observed only at extreme AMF conditions, and was due to nonspecific heating resulting from the AMF.

AB - Magnetic nanoparticles will heat when activated by an alternating magnetic field (AMF). Systemic delivery of magnetic nanoparticles conjugated to a monoclonal antibody (MAb) offers potential for selective and minimally invasive cancer treatment by heating the microenvironments of cells containing such particles. 111In-Chimeric L6 (Ch L6) antibody was conjugated to carboxylated polyethylene glycol (PEG-COOH) on dextran-coated iron oxide 20-nm particles to yield bioprobes. Pharmaco-kinetics, histopathology, and AMF/bioprobe therapy were done using intravenous doses (20μg/2.2mg ChL6/ bioprobe) with 50μg ChL6 in athymic mice bearing human breast tumor, HBT3477, xenografts. A 153 kHz AMF was applied 72 hr post injection for therapy using several AMF amplitudes. Significant therapeutic response was demonstrated. Toxicity was observed only at extreme AMF conditions, and was due to nonspecific heating resulting from the AMF.

KW - Cancer

KW - Magnetic nanoparticles

KW - Monoclonal antibodies (MAb)

KW - Thermoablation

UR - http://www.scopus.com/inward/record.url?scp=33845199704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845199704&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:33845199704

SN - 0976798573

SN - 9780976798576

VL - 2

SP - 21

EP - 24

BT - 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings

ER -